| scholarly article | Q13442814 |
| P2093 | author name string | Wang T | |
| Lin Y | |||
| Farley J | |||
| Gruendler C | |||
| P2860 | cites work | A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation | Q22003817 |
| TGF-beta signal transduction | Q22003891 | ||
| Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein | Q22010706 | ||
| Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling | Q24290353 | ||
| Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase | Q24290743 | ||
| Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation | Q24290777 | ||
| Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation | Q24291000 | ||
| Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12 | Q24305896 | ||
| MADR1, a MAD-related protein that functions in BMP2 signaling pathways | Q24317247 | ||
| Serine phosphorylation, chromosomal localization, and transforming growth factor-beta signal transduction by human bsp-1 | Q24322007 | ||
| Structure and functions of the 20S and 26S proteasomes | Q24328777 | ||
| Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly | Q27931608 | ||
| Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme | Q28117992 | ||
| TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
| Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2 | Q28283345 | ||
| Smads: transcriptional activators of TGF-beta responses | Q28292325 | ||
| SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling | Q28608960 | ||
| Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components | Q29036482 | ||
| Bone morphogenetic proteins: multifunctional regulators of vertebrate development | Q29618986 | ||
| Regulation of Smad activity | Q33830190 | ||
| ATP-Dependent inactivation and sequestration of ornithine decarboxylase by the 26S proteasome are prerequisites for degradation | Q33959864 | ||
| The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms | Q34349039 | ||
| Regulation of cartilage and bone differentiation by bone morphogenetic proteins | Q35455538 | ||
| The transforming growth factor beta family and induction of the vertebrate mesoderm: bone morphogenetic proteins are ventral inducers | Q35843521 | ||
| Cloning and characterization of mouse Lmp3 cDNA, encoding a proteasome beta subunit | Q36867421 | ||
| Ubiquitin-dependent degradation of TGF-beta-activated smad2. | Q40913405 | ||
| Mechanism of TGFbeta receptor inhibition by FKBP12 | Q41101968 | ||
| Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome | Q41197961 | ||
| Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination | Q41589996 | ||
| SMADs: mediators and regulators of TGF-beta signaling | Q41732765 | ||
| Processing of N3, a mammalian proteasome beta-type subunit | Q42111030 | ||
| Distinct domains of antizyme required for binding and proteolysis of ornithine decarboxylase | Q42267971 | ||
| The N terminus of antizyme promotes degradation of heterologous proteins | Q46207297 | ||
| TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins | Q47851514 | ||
| MAD-related proteins in TGF-beta signalling. | Q52198314 | ||
| The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. | Q52549447 | ||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | morphogenesis | Q815547 |
| P304 | page(s) | 46533-46543 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Proteasomal degradation of Smad1 induced by bone morphogenetic proteins | |
| P478 | volume | 276 |
| Q21284180 | A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs). |
| Q35633536 | A synthetic time-delay circuit in mammalian cells and mice |
| Q57291214 | Antizyme Inhibitors in Polyamine Metabolism and Beyond: Physiopathological Implications |
| Q38674343 | Antizyme affects cell proliferation and viability solely through regulating cellular polyamines |
| Q37462415 | Antizyme and antizyme inhibitor, a regulatory tango |
| Q28074076 | Antizyme inhibitor 1: a potential carcinogenic molecule |
| Q52107801 | Antizyme is a target of sex-lethal in the Drosophila germline and appears to act downstream of hedgehog to regulate sex-lethal and cyclin B. |
| Q34762106 | Artificial mammalian gene regulation networks-novel approaches for gene therapy and bioengineering |
| Q44350476 | BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels |
| Q33960631 | Cachexia: a therapeutic approach beyond cytokine antagonism |
| Q36915734 | Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors |
| Q92012192 | Critical Factors in Human Antizymes that Determine the Differential Binding, Inhibition, and Degradation of Human Ornithine Decarboxylase |
| Q38890041 | Effect of Oaz1 overexpression on goose ovarian granulosa cells. |
| Q35386279 | Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer |
| Q39787552 | Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein |
| Q24540250 | Identification of mZnf8, a mouse Krüppel-like transcriptional repressor, as a novel nuclear interaction partner of Smad1. |
| Q42797767 | Identification of nuclear export signals in antizyme-1. |
| Q53208281 | Interaction between Smad1 and p97/VCP in rat testis and epididymis during the postnatal development. |
| Q24529004 | Interaction of U-box E3 ligase SNEV with PSMB4, the beta7 subunit of the 20 S proteasome |
| Q42175695 | Intra-axonal translation of SMAD1/5/8 mediates retrograde regulation of trigeminal ganglia subtype specification |
| Q35757453 | Involvement of Antizyme Characterized from the Small Abalone Haliotis diversicolor in Gonadal Development |
| Q49503028 | Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells |
| Q36638469 | Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo |
| Q52725505 | Local BMP receptor activation at adherens junctions in the Drosophila germline stem cell niche. |
| Q28258468 | Mouse ornithine decarboxylase-like gene encodes an antizyme inhibitor devoid of ornithine and arginine decarboxylating activity |
| Q36414339 | Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor |
| Q35163981 | New intracellular components of bone morphogenetic protein/Smad signaling cascades |
| Q47956518 | Notch signaling pathway and gene expression profiles during early in vitro differentiation of liver-derived mesenchymal stromal cells to osteoblasts. |
| Q36330102 | OAZ1 knockdown enhances viability and inhibits ER and LHR transcriptions of granulosa cells in geese |
| Q53119767 | Polyamine signal through gap junctions: A key regulator of proliferation and gap-junction organization in mammalian tissues? |
| Q35648890 | Polyamine-independent Expression of Caenorhabditis elegans Antizyme |
| Q39655801 | Proteasomal degradation of cytotoxic necrotizing factor 1-activated rac. |
| Q38298136 | Proteins directly interacting with mammalian 20S proteasomal subunits and ubiquitin-independent proteasomal degradation |
| Q37679977 | Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor |
| Q35691559 | Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation |
| Q34279291 | Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1 |
| Q26970809 | Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use |
| Q33614939 | Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation |
| Q57792063 | The Antizyme family for regulating polyamines |
| Q34801788 | To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins |
| Q46884912 | Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis. |
| Q50298213 | Ubiquitin-dependent degradation of the Smad complex terminates BMP2 signalling |
| Q35082727 | Ubiquitin-dependent regulation of TGFbeta signaling in cancer |
| Q28513192 | Yeast two-hybrid screens imply that GGNBP1, GGNBP2 and OAZ3 are potential interaction partners of testicular germ cell-specific protein GGN1 |
| Q41567346 | ZC4H2 stabilizes Smads to enhance BMP signalling, which is involved in neural development in Xenopus. |
Search more.